Christopher Filson MD MS
Minimally Invasive Surgery, Surgical Oncology
Physician
Join to View Full Profile
4900 W Sunset BlvdLos Angeles, CA 90027
Dr. Filson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- I am a board-certified urologic oncologist with an interest in urologic oncology, robotic surgery, and health services research. My research focus is learning how to optimize use of novel imaging studies like multi-parametric MRI of the prostate to improve our ability to accurately diagnose and stage prostate cancer.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Minimally Invasive Urologic Surgery, 2013 - 2015
University of Michigan Medical CenterFellowship, Health Services Research, 2012 - 2013- University of MichiganResidency, Urology, 2007 - 2012
University of MichiganMS, Health and Health Care Research, 2009 - 2010- University of MichiganInternship, Surgery, 2006 - 2007
University of Michigan Medical SchoolClass of 2006
Certifications & Licensure
CA State Medical License 2023 - 2025
GA State Medical License 2015 - 2024
MI State Medical License 2006 - 2016
American Board of Urology Urology
Awards, Honors, & Recognition
- Member Western Section AUA, 2023
- Member Southeastern Section of AUA, 2015-2023
- Member Society of Urologic Oncology, 2013-2018
- Join now to see all
Publications & Presentations
PubMed
- Neoadjuvant cabozantinib for locally advanced nonmetastatic clear cell renal cell carcinoma: a phase 2 trial.Mehmet A Bilen, BaoHan T Vo, Yuan Liu, Rachel Greenwald, Amir H Davarpanah
Nature Cancer. 2025-03-01 - 1 citationsExposure to the herbicide 2,4-dichlorophenoxyacetic acid and prostate cancer among U.S. adult men.Frank Glover, Michael Eisenberg, Francesco Del Giudice, Federico Belladelli, Albert Ha
World Journal of Urology. 2024-11-01 - Tailoring language for genitourinary function in patients with newly diagnosed prostate cancer to facilitate discussions in diverse populations and overcome health lit...Kerry L Kilbridge, Dattatraya Patil, Christopher Paul Filson, Joseph W Shelton, Sierra Williams Thomson
Cancer. 2024-10-15
Journal Articles
- Association of State-Level Medicaid Expansion with Treatment of Patients with Higher-Risk Prostate CancerChristopher Filson, MD, JAMA Network Open
- Impact of Prebiopsy Magnetic Resonance Imaging of the Prostate on Cancer Detection and Treatment PatternsMartin G Sanda, Christopher P Filson, Urologic Oncology
Authored Content
- The Resurgence of Metastatic Prostate Cancer: Not So Fast, But Get ReadyJuly 2016
Press Mentions
Enhanced Antibiotic Prophylaxis and Infection-Related Complications Following Prostate BiopsyMarch 26th, 2021
More Metastatic Prostate Cancers Diagnosed Following USPSTF Screening RecommendationsFebruary 3rd, 2020
USPSTF Prostate Screening Guidance Had ImpactMay 22nd, 2018- Join now to see all
Grant Support
- MRI-guided Prostate Biopsy: Maximizing Value and Optimizing UtilizationAmerican Cancer Society2018–2022
- ACS Postdoctoral FellowshipAmerican Cancer Society2015
- Ruth L Kirschstein T32 Research FellowshipNational Institutes of Health2009–2012
- Munn Idea GrantUniversity of Michigan Comprehensive Cancer Center2009–2010
- Urology Care Foundation Research Scholars Program Postdoctoral AwardAmerican Urological AssociationPresent
Professional Memberships
- Member
- Member
- Society of Urologic OncologyMember
- Member
External Links
- Winship Cancer Institutehttps://winshipcancer.emory.edu/bios/faculty/filson-christopher.html
- Emory Accounthttp://urology.emory.edu/about-us/faculty-directory/filson_christopher_p_uro_faculty_profile.html
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
